Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma. - Wikidata - wikimedia - TriplyDB

Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.

Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.

http://www.wikidata.org/entity/Q40168004

about

Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.Six degrees of separation: the oxygen effect in the development of radiosensitizers.Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.Should modulation of p50 be a therapeutic target in the critically ill?Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2.Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.Exploring the origins of structure–oxygen affinity relationship of human haemoglobin allosteric effector

P2860

Q30540976-A86B4A14-4C45-4729-8DA8-AEEEA2CA3C48 Q35116798-FA32528B-DF1E-4781-B944-EC51ADAC9B45 Q36166723-E9E65D75-6681-46A0-9B09-F6311B827BA8 Q36544108-85CCF736-D79B-41CB-B665-69AE97E751F0 Q38098095-330FC0F5-A505-49B6-8CFE-C2E4328F8421 Q38974193-4E223FEB-E1BA-4276-8B24-B37041281577 Q39237387-5821B314-D59E-4A65-9AFF-31E30B8F3BD9 Q39263962-0C031A72-964E-414E-890E-A44703B5C36F Q50543861-70C44AC3-82B2-4E2C-AE4B-73DEA8AADA74 Q57011482-96545ED4-6D54-43BC-B0E2-E118C8848339

P2860

Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.

http://www.wikidata.org/entity/Q40168004

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Anti-angiogenic properties of ...... reduction of implanted glioma.

@en

type

label

Anti-angiogenic properties of ...... reduction of implanted glioma.

@en

prefLabel

Anti-angiogenic properties of ...... reduction of implanted glioma.

@en

P1433

Q40168004-8717C7FA-68B9-4AB8-A5C8-4C241055458B

P1476

Q40168004-5441151B-A7A9-465D-85CB-510FF64FBF8F

P2093

Q40168004-423FA9BD-B434-420E-B81A-D47747B24225

Q40168004-8154578A-2CCB-45A8-9831-32E3D7713BF8

Q40168004-8BB00A15-5129-40D4-8F91-82F8AD44F2D3

Q40168004-9A57F6E3-007A-4786-8A2D-12E6714D0B23

Q40168004-F1B0EEB6-317C-4033-9FB5-D78B8D94080B

Q40168004-F54F7DDA-1E75-4CE8-9D13-3927DB9BDF8E

P2860

Q40168004-4F70F868-71BD-4437-8AE2-38C5103E9968

Q40168004-5BC6AE11-730B-4094-B7F4-45C955AC9340

Q40168004-5FB14E14-23E1-4F8F-AC22-BE8BFE49ADE8

Q40168004-6314AEDD-9201-4379-9A10-3CFCEC1BDAB6

Q40168004-9399A803-7CBA-4314-9D0B-0FD92DD26FD1

Q40168004-B40F7E8A-F2D5-4FB6-AD07-E45283DD42D2

Q40168004-BFFF3368-2448-459F-A978-AD1A2AD9F314

Q40168004-C444B35C-5B23-4E55-BE13-2668C4128D44

Q40168004-D541E7E3-5955-4B49-A72E-6DB428A6A4B3

Q40168004-D6BC2726-F082-4D7E-A967-D0AB01DA2C17

P304

Q40168004-3DA6B916-F083-4BFD-9593-3D330A9C4120

P31

Q40168004-4FFD5AF6-D3E7-49DF-B1A3-31F8A9AF1A15

P356

Q40168004-2B6F7827-FD59-4D24-AA41-A5AC29D2C7BB

P407

Q40168004-6E88B56D-A330-4C5C-B5DF-7E390226113D

P433

Q40168004-9B4B8196-E5A4-411C-9353-CEC75C1B8260

P478

Q40168004-625DB662-8718-463F-83DF-5275AF962D56

P50

Q40168004-07DDAAB6-B4C5-49D8-974D-83AD08AE5E02

Q40168004-6F719947-1F00-474B-B6ED-8EF252152007

Q40168004-C3A39191-4B44-498F-8D30-DC1C635B4D96

P577

Q40168004-98E3DCFB-DEC7-4537-A298-03755236522D

P5875

Q40168004-A57A364E-03C2-41D1-BA74-4C513881B58D

P698

Q40168004-292A19FB-86E2-4A41-A15D-743D9FAB0A21

P356

J.FEBSLET.2007.01.079

P1433

P1476

Anti-angiogenic properties of ...... reduction of implanted glioma.

@en

P2093

Claude Nicolau

http://www.w3.org/2001/XMLSchema#string

Gabin Sihn

http://www.w3.org/2001/XMLSchema#string

Hiroshi Iwao

http://www.w3.org/2001/XMLSchema#string

Isabelle Queguiner

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Klein

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Gasc

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

Accessing key steps of human tumor progression in vivo by using an avian embryo model.

Antioxidant functions of phytic acid.

Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.

Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Hypoxia signalling in cancer and approaches to enforce tumour regression.

Predicting benefit from anti-angiogenic agents in malignancy.

Anti-angiogenic activity of inositol hexaphosphate (IP6).

Angiotensinogen and its cleaved derivatives inhibit angiogenesis.

Detection of blood vessels in retinal images using two-dimensional matched filters.

P304

962-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2007.01.079

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

581

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Marie Lehn

P577

2007-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6488803

http://www.w3.org/2001/XMLSchema#string

P698

17316624

http://www.w3.org/2001/XMLSchema#string